No Data
No Data
SPDR S&P Biotech ETF Options Spot-On: On September 19th, 109.02K Contracts Were Traded, With 1 Million Open Interest
On September 19th ET, $SPDR S&P Biotech ETF(XBI.US)$ had active options trading, with a total trading volume of 109.02K options for the day, of which put options accounted for 19.38% of the total
Behind the Scenes of Amgen's Latest Options Trends
Wells Fargo's 'Value Equity List' – Stocks With Potential That Trade at a Discount
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
Halozyme Cut to Neutral at J.P. Morgan on Valuation
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.